— Know what they know.
Not Investment Advice
Also trades as: 0QCV.L (LSE) · $vol 3M · 4AB.DE (XETRA) · $vol 0M · ABBV.BA (BUE) · $vol 0M · 4AB.DU (DUS) · $vol 0M

ABBV NYSE

AbbVie Inc.
1W: +1.8% 1M: +7.0% 3M: -4.5% YTD: -5.7% 1Y: +17.9% 3Y: +64.1% 5Y: +118.8%
$215.70
+1.20 (+0.56%)
 
Weekly Expected Move ±3.7%
$195 $203 $210 $218 $226
NYSE · Healthcare · Drug Manufacturers - General · Alpha Radar Buy · Power 64 · $381.1B mcap · 1.76B float · 0.383% daily turnover · Short 40% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
53.5 / 100
NoneWeakNarrowWide
Primary source: Efficient Scale  ·  ROIC: 18.4%  ·  5Y Avg: 10.4%
Cost Advantage
40
Intangibles
59
Switching Cost
42
Network Effect
50
Scale ★
85
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. ABBV shows a Weak competitive edge (53.5/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Efficient Scale. ROIC of 18.4% confirms the company is generating returns well above its cost of capital — a hallmark of durable competitive advantages.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$235
Low
$270
Avg Target
$298
High
Based on 3 analysts since Apr 29, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 28Hold: 12Sell: 1Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$264.50
Analysts8
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-05-15 Evercore ISI $228 $235 +7 +10.8% $212.04
2026-05-14 Piper Sandler $294 $298 +4 +42.9% $208.50
2026-04-30 Morgan Stanley $269 $278 +9 +31.0% $212.15
2026-04-23 Piper Sandler $299 $294 -5 +46.6% $200.49
2026-04-20 Canaccord Genuity Initiated $262 +28.6% $203.71
2026-04-10 Guggenheim Vamil Divan $242 $249 +7 +18.5% $210.15
2026-04-08 Cantor Fitzgerald $250 $240 -10 +13.4% $211.59
2026-02-24 RBC Capital Trung Huynh $135 $260 +125 +13.8% $228.44
2026-02-19 Barclays $195 $275 +80 +22.6% $224.35
2026-02-18 Piper Sandler $289 $299 +10 +28.4% $232.86
2026-02-05 UBS $240 $230 -10 +5.8% $217.41
2026-02-04 Evercore ISI Gavin Clark-Gartner $133 $228 +95 +5.1% $217.02
2026-01-28 Goldman Sachs Asad Haider Initiated $223 +1.5% $219.77
2026-01-20 Berenberg Bank $135 $275 +140 +28.3% $214.35
2026-01-15 BMO Capital Evan David Seigerman $215 $258 +43 +18.5% $217.74
2026-01-07 UBS $251 $240 -11 +7.2% $223.93
2025-12-12 Morgan Stanley $182 $269 +87 +20.9% $222.48
2025-12-10 HSBC $225 $265 +40 +18.8% $222.99
2025-11-05 Piper Sandler David Amsellem $284 $289 +5 +35.3% $213.57
2025-11-03 Raymond James Gary Nachman $250 $256 +6 +17.4% $218.04
2025-10-20 Guggenheim $171 $242 +71 +5.4% $229.57
2025-10-17 Raymond James Gary Nachman $220 $250 +30 +10.2% $226.87
2025-10-10 Piper Sandler $160 $284 +124 +23.1% $230.69
2025-10-09 Cantor Fitzgerald $245 $250 +5 +8.1% $231.24
2025-10-03 UBS $147 $251 +104 +6.1% $236.56
2025-10-02 HSBC $185 $225 +40 -7.9% $244.38
2025-09-15 Cantor Fitzgerald Carter Gould $200 $245 +45 +12.2% $218.34
2025-02-03 Raymond James Gary Nachman $209 $220 +11 +15.7% $190.14
2025-02-03 BMO Capital Evan Seigerman $208 $215 +7 +13.1% $190.14
2024-11-12 BMO Capital Evan David Seigerman $228 $208 -20 +3.2% $201.61
2024-10-31 BMO Capital Evan David Seigerman $214 $228 +14 +13.2% $201.50
2024-10-31 Bank of America Securities Charlie Yang $195 $210 +15 +4.2% $201.50
2024-10-31 Citigroup Geoff Meacham $155 $226 +71 +12.2% $201.50
2024-10-18 Bank of America Securities Geoff Meacham Initiated $195 +3.4% $188.57
2024-10-17 Bernstein Courtney Breen $155 $203 +48 +6.6% $190.46
2024-08-23 Raymond James Christopher Raymond $190 $209 +19 +5.9% $197.35
2024-07-19 BMO Capital Evan Seigerman $180 $214 +34 +24.4% $172.01
2024-06-18 Raymond James Christopher Raymond $170 $190 +20 +10.9% $171.36
2024-06-05 HSBC Rajesh Kumar Initiated $185 +14.1% $162.14
2024-05-24 Deutsche Bank James Shin Initiated $175 +11.5% $156.96
2024-05-17 Cantor Fitzgerald Louise Chen Initiated $200 +21.7% $164.35
2024-04-29 BMO Capital Evan Seigerman $167 $180 +13 +13.5% $158.58
2024-03-26 Barclays Carter Gould $160 $195 +35 +8.5% $179.79
2024-01-29 William Blair Tim Lugo Initiated $190 +15.9% $163.91
2023-11-09 Raymond James Christopher Raymond $177 $170 -7 +19.7% $142.03
2023-09-29 Raymond James Gary Nachman Initiated $177 +18.7% $149.12
2023-05-09 Guggenheim Vamil Divan Initiated $171 +16.3% $147.01
2023-02-06 BMO Capital $174 $167 -7 +14.8% $145.49
2022-12-06 Morgan Stanley $191 $182 -9 +11.4% $163.44
2022-11-17 Credit Suisse Initiated $170 +11.7% $152.16

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

B-
May 22, 2026
DCF
4
ROE
4
ROA
4
D/E
1
P/E
1
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. ABBV receives an overall rating of B-. Strongest factors: DCF (4/5), ROE (4/5), ROA (4/5). Areas of concern: D/E (1/5), P/E (1/5), P/B (1/5).
Rating Change History
DateFromTo
2026-05-11 C- B-
2026-04-30 C+ C-
2026-03-02 C C+
2026-02-23 C+ C
2026-02-21 C- C+
2026-02-05 C C-
2026-01-26 C+ C

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

64 Grade A
Profitability
65
Balance Sheet
20
Earnings Quality
54
Growth
61
Value
37
Momentum
68
Safety
50
Cash Flow
88
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. ABBV scores highest in Cash Flow (88/100) and lowest in Balance Sheet (20/100). An overall grade of A places ABBV among the highest-quality companies in its peer group.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
2.07
Grey Zone
Piotroski F-Score
6/9
Beneish M-Score
-2.99
Unlikely Manipulator
Ohlson O-Score
-7.34
Bankruptcy prob: 0.1%
Low Risk
Credit Rating
BB+
Score: 45.8/100
Trend: Improving
Earnings Quality
75/100
OCF/NI: 5.82x
Accruals: -13.1%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. ABBV scores 2.07, placing it in the Grey Zone (safe > 2.99, distress < 1.81). Financial distress is possible and warrants monitoring. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. ABBV scores 6/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. ABBV's score of -2.99 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. ABBV's implied 0.1% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. ABBV receives an estimated rating of BB+ (score: 45.8/100), with a improving trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). ABBV's score of 75/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
105.14x
PEG
-7.97x
P/S
6.07x
P/B
13.91x
P/FCF
18.34x
P/OCF
18.03x
EV/EBITDA
26.39x
EV/Revenue
7.11x
EV/EBIT
50.25x
EV/FCF
21.40x
Earnings Yield
0.95%
FCF Yield
5.45%
Shareholder Yield
3.48%
Graham Number
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 105.1x earnings, ABBV is priced for high growth expectations.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.610
NI / EBT
×
Interest Burden
0.672
EBT / EBIT
×
EBIT Margin
0.141
EBIT / Rev
×
Asset Turnover
0.467
Rev / Assets
×
Equity Multiplier
4893.109
Assets / Equity
=
ROE
13254.5%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. ABBV's ROE of 13254.5% is driven by financial leverage (equity multiplier: 4893.11x). Note: high leverage means ROE is amplified by debt rather than operational performance.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
$17.46
Price/Value
12.35x
Margin of Safety
-1135.06%
Premium
1135.06%
Assessment
Overvalued
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with ABBV's realized 0.0% 3-year EPS CAGR — what the company actually delivered, not what analysts hope for. ABBV trades at a 1135% premium to its adjusted intrinsic value of $17.46, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 8.5x compares to the current market P/E of 105.1x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$215.70
Median 1Y
$249.95
5th Pctile
$164.93
95th Pctile
$378.94
Ann. Volatility
25.6%
Analyst Target
$264.50
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Robert A. Michael
Chairman of the Board and Chief Executive Officer
$1,700,000 $13,268,456 $32,530,984
Jeffrey R. Stewart
Executive Vice President, Chief Commercial Officer
$1,315,726 $5,390,310 $15,435,304
Scott T. Reents
Executive Vice President, Chief Financial Officer
$1,124,116 $4,353,512 $12,353,002
Azita Saleki-Gerhardt President,
Vice President, Chief Operations Officer
$1,052,581 $3,980,457 $10,791,976
Roopal B. Thakkar
Executive Vice President, Research & Development and Chief Scientific Officer
$1,146,154 $3,980,457 $9,912,843

CEO Pay Ratio

132:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $32,530,984
Avg Employee Cost (SGA/emp): $245,789
Employees: 57,000

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
57,000
+3.6% YoY
Revenue / Employee
$1,072,982
Rev: $61,160,000,000
Profit / Employee
$74,140
NI: $4,226,000,000
SGA / Employee
$245,789
Avg labor cost proxy
R&D / Employee
$159,579
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE 2.7% 3.1% 81.0% 87.6% 88.7% 94.1% 72.5% 46.4% 53.2% 39.9% 35.2% 43.4% 38.7% 37.1% 62.5% 61.3% 55.1% 35.0% 153.9% 132.5% 132.55%
ROA 5.6% 6.3% 7.8% 8.4% 8.5% 9.0% 8.3% 5.3% 6.1% 4.6% 3.6% 4.4% 3.9% 3.7% 3.2% 3.1% 2.8% 1.8% 3.1% 2.7% 2.71%
ROIC 18.8% 18.9% 19.2% 19.8% 18.8% 19.3% 22.0% 18.8% 20.0% 17.0% 17.2% 17.7% 16.1% 17.1% 16.1% 17.8% 22.6% 22.0% 18.3% 18.4% 18.43%
ROCE 7.0% 7.9% 13.8% 14.7% 14.7% 15.3% 14.4% 10.3% 11.6% 9.4% 8.7% 10.2% 9.9% 10.2% 6.8% 6.7% 6.1% 4.7% 10.5% 9.8% 9.80%
Gross Margin 67.6% 69.4% 71.0% 70.1% 71.4% 66.1% 72.4% 67.4% 69.4% 53.4% 60.1% 66.7% 70.9% 70.9% 70.9% 70.0% 84.4% 66.4% 72.6% 71.9% 71.88%
Operating Margin 31.8% 30.0% 34.1% 34.8% 22.6% 31.1% 36.4% 22.6% 32.5% 16.4% 22.3% 22.7% 27.6% 26.5% -9.9% 28.0% 38.0% 12.1% 35.0% 31.6% 31.56%
Net Margin 5.5% 22.2% 27.2% 33.2% 6.3% 26.7% 16.4% 2.0% 14.6% 12.8% 5.7% 11.1% 9.5% 10.8% -0.1% 9.6% 6.1% 1.2% 10.9% 4.7% 4.66%
EBITDA Margin 28.5% 44.7% 45.9% 55.6% 26.0% 48.4% 37.6% 25.8% 39.1% 34.1% 26.9% 36.5% 34.6% 33.8% 3.5% 33.0% 28.2% 22.3% 32.3% 24.6% 24.61%
FCF Margin 36.4% 39.3% 39.1% 38.9% 38.7% 37.9% 41.8% 41.5% 44.3% 44.8% 40.6% 40.2% 32.3% 28.1% 31.7% 26.8% 31.3% 34.5% 30.6% 33.2% 33.21%
OCF Margin 38.1% 40.9% 40.5% 40.2% 40.0% 39.1% 43.0% 42.7% 45.6% 46.3% 42.0% 41.7% 33.9% 29.7% 33.4% 28.6% 33.1% 35.0% 31.1% 33.8% 33.79%
ROA 3Y Avg snapshot only 3.42%
ROIC 3Y Avg snapshot only 8.76%
ROIC Economic snapshot only 17.29%
Cash ROA snapshot only 15.84%
Cash ROIC snapshot only 35.06%
CROIC snapshot only 34.46%
NOPAT Margin snapshot only 17.76%
Pretax Margin snapshot only 9.51%
R&D / Revenue snapshot only 15.08%
SGA / Revenue snapshot only 22.70%
SBC / Revenue snapshot only 1.57%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio 25.30 21.68 17.99 20.12 18.91 15.77 21.75 33.75 25.08 37.40 52.64 50.70 54.04 65.49 71.16 86.32 85.90 170.15 95.78 104.98 105.145
P/S Ratio 3.14 2.96 3.69 4.43 4.17 3.66 4.43 4.51 3.89 4.42 4.71 5.58 5.25 6.04 5.40 6.31 5.55 6.83 6.63 6.09 6.067
P/B Ratio 12.89 12.49 13.47 16.30 15.51 13.72 14.92 14.84 12.62 14.12 24.71 29.33 27.85 32.38 91.56 108.90 97.37 122.51 -123.96 -117.02 13.914
P/FCF 8.61 7.53 9.44 11.39 10.76 9.64 10.62 10.88 8.78 9.85 11.60 13.88 16.23 21.47 17.07 23.54 17.75 19.80 21.67 18.34 18.339
P/OCF 8.24 7.24 9.11 11.01 10.43 9.36 10.32 10.57 8.53 9.55 11.21 13.39 15.48 20.32 16.19 22.08 16.79 19.53 21.30 18.03 18.029
EV/EBITDA 14.28 13.23 11.50 12.88 12.49 11.03 12.92 15.71 12.73 15.71 17.66 18.97 18.57 21.00 24.59 28.63 27.26 36.70 26.61 26.39 26.385
EV/Revenue 4.60 4.38 4.90 5.62 5.35 4.83 5.38 5.48 4.87 5.42 5.58 6.45 6.11 6.89 6.51 7.40 6.62 7.87 7.67 7.11 7.107
EV/EBIT 28.98 24.98 17.87 19.46 18.76 16.39 19.89 27.62 21.51 29.19 35.79 35.61 35.09 38.79 56.21 65.59 65.52 103.42 49.44 50.25 50.249
EV/FCF 12.63 11.16 12.52 14.46 13.81 12.73 12.88 13.22 11.00 12.07 13.75 16.04 18.89 24.50 20.56 27.58 21.17 22.83 25.09 21.40 21.398
Earnings Yield 4.0% 4.6% 5.6% 5.0% 5.3% 6.3% 4.6% 3.0% 4.0% 2.7% 1.9% 2.0% 1.9% 1.5% 1.4% 1.2% 1.2% 0.6% 1.0% 1.0% 0.95%
FCF Yield 11.6% 13.3% 10.6% 8.8% 9.3% 10.4% 9.4% 9.2% 11.4% 10.1% 8.6% 7.2% 6.2% 4.7% 5.9% 4.2% 5.6% 5.0% 4.6% 5.5% 5.45%
EV/OCF snapshot only 21.036
EV/Gross Profit snapshot only 9.634
Acquirers Multiple snapshot only 24.385
Shareholder Yield snapshot only 3.48%
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 0.84 0.84 0.79 0.79 0.79 0.79 0.96 0.96 0.96 0.96 0.87 0.87 0.87 0.87 0.66 0.66 0.66 0.66 0.67 0.67 0.671
Quick Ratio 0.73 0.73 0.70 0.70 0.70 0.70 0.84 0.84 0.84 0.84 0.76 0.76 0.76 0.76 0.55 0.55 0.55 0.55 0.56 0.56 0.557
Debt/Equity 6.66 6.66 5.03 5.03 5.03 5.03 3.72 3.72 3.72 3.72 5.80 5.80 5.80 5.80 20.40 20.40 20.40 20.40 -21.12 -21.12 -21.122
Net Debt/Equity 6.01 6.01 4.40 4.40 4.40 4.40 3.19 3.19 3.19 3.19 4.57 4.57 4.57 4.57 18.73 18.73 18.73 18.73
Debt/Assets 0.58 0.58 0.53 0.53 0.53 0.53 0.46 0.46 0.46 0.46 0.45 0.45 0.45 0.45 0.50 0.50 0.50 0.50 0.52 0.52 0.516
Debt/EBITDA 5.03 4.76 3.24 3.13 3.16 3.06 2.66 3.24 3.00 3.38 3.50 3.25 3.32 3.30 4.55 4.58 4.79 5.30 3.92 4.08 4.082
Net Debt/EBITDA 4.54 4.30 2.83 2.74 2.76 2.68 2.27 2.78 2.56 2.89 2.75 2.56 2.62 2.60 4.18 4.20 4.40 4.87 3.62 3.77 3.771
Interest Coverage 3.40 3.92 6.36 7.01 7.17 7.59 7.04 5.04 5.68 4.60 3.81 4.23 3.82 3.70 2.32 2.27 2.06 1.58 3.28 3.05 3.053
Equity Multiplier 11.51 11.51 9.51 9.51 9.51 9.51 8.04 8.04 8.04 8.04 13.00 13.00 13.00 13.00 40.65 40.65 40.65 40.65 -40.97 -40.97 -40.966
Cash Ratio snapshot only 0.121
Debt Service Coverage snapshot only 5.815
Cash to Debt snapshot only 0.076
FCF to Debt snapshot only 0.302
Defensive Interval snapshot only 232.4 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.45 0.46 0.38 0.38 0.39 0.39 0.41 0.40 0.39 0.39 0.40 0.40 0.40 0.41 0.42 0.43 0.43 0.44 0.45 0.47 0.467
Inventory Turnover 7.21 6.95 5.42 5.37 5.26 5.46 5.19 5.17 5.19 5.63 5.32 5.35 5.34 4.74 4.08 4.06 3.63 3.89 3.56 3.61 3.609
Receivables Turnover 7.54 7.74 5.98 6.03 6.10 6.15 5.47 5.35 5.28 5.19 4.85 4.86 4.91 4.96 5.10 5.20 5.28 5.40 5.20 5.34 5.344
Payables Turnover 9.91 9.55 6.76 6.70 6.57 6.81 5.99 5.97 5.99 6.49 6.17 6.20 6.19 5.50 5.10 5.07 4.53 4.86 4.98 5.04 5.041
DSO 48 47 61 60 60 59 67 68 69 70 75 75 74 74 72 70 69 68 70 68 68.3 days
DIO 51 52 67 68 69 67 70 71 70 65 69 68 68 77 89 90 101 94 102 101 101.1 days
DPO 37 38 54 54 56 54 61 61 61 56 59 59 59 66 72 72 81 75 73 72 72.4 days
Cash Conversion Cycle 62 61 74 74 74 73 76 78 78 79 85 85 84 84 89 88 89 86 99 97 97.0 days
Fixed Asset Turnover snapshot only 9.869
Operating Cycle snapshot only 169.4 days
Cash Velocity snapshot only 11.950
Capital Intensity snapshot only 2.132
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 48.3% 35.7% 22.7% 13.0% 6.7% 4.8% 3.3% 0.0% -2.3% -4.6% -6.4% -4.1% -1.8% 0.7% 3.7% 5.4% 6.1% 7.4% 8.6% 9.5% 9.50%
Net Income -4.2% 2.1% 1.5% 1.4% 89.7% 78.0% 2.5% -39.2% -31.3% -51.4% -58.9% -21.0% -38.5% -21.4% -12.0% -30.0% -29.4% -53.3% -1.1% -13.1% -13.11%
EPS -11.2% 1.9% 1.5% 1.4% 89.7% 78.1% 2.5% -39.1% -31.1% -51.3% -58.8% -20.9% -38.5% -21.4% -12.1% -30.0% -29.4% -53.3% -1.1% -13.2% -13.21%
FCF 38.7% 41.4% 31.0% 23.9% 13.5% 1.1% 10.3% 6.7% 11.6% 12.8% -9.0% -6.9% -28.3% -36.8% -19.2% -29.7% 2.6% 31.7% 4.9% 35.6% 35.62%
EBITDA 34.7% 19.7% 94.2% 67.0% 42.0% 38.4% 1.0% -20.0% -12.8% -24.9% -29.0% -6.5% -15.6% -4.1% -13.2% -19.9% -21.7% -29.8% 18.2% 14.2% 14.17%
Op. Income 42.3% 43.6% 57.7% 56.3% 11.8% 6.5% 1.1% -12.8% -0.0% -14.8% -29.6% -20.9% -29.4% -8.2% -28.4% -21.2% -2.7% -27.6% 89.4% 81.8% 81.78%
OCF Growth snapshot only 29.41%
Asset Growth snapshot only -0.89%
Equity Growth snapshot only -1.98%
Debt Growth snapshot only 1.81%
Shares Change snapshot only 0.11%
Dividend Growth snapshot only 5.73%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y 20.2% 19.7% 19.7% 20.2% 20.7% 20.7% 20.4% 18.5% 15.6% 10.7% 5.8% 2.7% 0.8% 0.2% 0.1% 0.4% 0.6% 1.0% 1.8% 3.5% 3.45%
Revenue 5Y 16.8% 16.9% 17.0% 16.7% 16.5% 16.2% 15.5% 13.9% 12.6% 11.4% 10.6% 10.8% 11.0% 11.1% 11.1% 11.0% 10.0% 8.0% 6.0% 4.6% 4.59%
EPS 3Y -2.9% -5.3% 19.1% 24.8% 36.9% 50.9% 7.8% -9.1% 5.1% -4.0% 1.9% 5.2% -7.0% -12.0% -28.1% -30.4% -33.1% -43.6% -29.0% -21.6% -21.64%
EPS 5Y 1.4% 2.7% 12.1% 12.3% 11.5% 12.7% 15.0% 1.3% 3.6% -5.9% -6.5% -1.3% 1.7% 5.7% -14.6% -16.1% -12.8% -20.1% -1.6% -6.7% -6.70%
Net Income 3Y 1.1% -0.1% 26.6% 32.5% 45.3% 60.3% 14.5% -3.5% 7.7% -4.1% 1.8% 5.1% -7.1% -12.1% -28.2% -30.5% -33.2% -43.7% -29.0% -21.7% -21.67%
Net Income 5Y 3.1% 4.4% 14.2% 14.6% 13.8% 15.1% 17.4% 3.5% 6.1% -2.9% -3.1% 2.3% 5.3% 9.5% -11.5% -13.0% -11.5% -20.2% -1.7% -6.7% -6.71%
EBITDA 3Y 16.5% 16.0% 42.3% 44.6% 51.3% 57.1% 25.5% 15.0% 18.6% 7.6% 11.7% 7.7% 1.5% -0.1% -14.6% -15.7% -16.8% -20.3% -10.0% -5.1% -5.10%
EBITDA 5Y 13.1% 13.1% 18.8% 18.5% 17.5% 17.8% 18.4% 12.1% 14.4% 10.2% 15.6% 17.7% 20.6% 22.8% 4.0% 2.6% 2.0% -3.5% 7.4% 2.7% 2.69%
Gross Profit 3Y 15.0% 15.6% 15.7% 16.2% 17.0% 16.6% 16.3% 14.3% 13.2% 9.1% 3.7% 1.4% -0.7% -0.0% 0.6% 0.9% 2.3% 2.6% 3.4% 5.6% 5.56%
Gross Profit 5Y 12.8% 13.9% 14.4% 14.4% 14.5% 13.9% 13.9% 12.1% 10.7% 8.4% 6.3% 6.1% 6.4% 8.0% 8.8% 9.0% 10.2% 9.3% 8.1% 7.3% 7.33%
Op. Income 3Y 15.3% 16.1% 41.1% 41.9% 34.6% 39.0% 11.7% 6.0% 16.7% 9.2% 3.9% 2.5% -7.6% -5.9% -20.1% -18.4% -11.8% -17.3% -1.5% 4.2% 4.23%
Op. Income 5Y 12.4% 12.7% 13.8% 14.3% 12.2% 11.8% 13.6% 10.0% 11.4% 7.2% 14.9% 14.5% 11.5% 16.0% -6.8% -5.8% 1.8% -2.9% 8.8% 9.1% 9.07%
FCF 3Y 21.8% 22.1% 19.8% 18.7% 20.3% 19.2% 23.8% 20.2% 20.7% 17.3% 9.5% 7.2% -3.2% -10.3% -6.7% -11.3% -6.4% -2.1% -8.3% -3.9% -3.91%
FCF 5Y 20.7% 25.5% 27.4% 27.4% 27.3% 21.0% 20.8% 18.8% 18.0% 15.7% 11.5% 10.7% 6.8% 3.9% 6.9% 2.6% 5.3% 6.1% 2.2% 3.2% 3.24%
OCF 3Y 21.6% 21.4% 19.3% 18.2% 19.6% 18.9% 23.2% 19.7% 20.1% 16.8% 9.1% 6.7% -3.0% -9.9% -6.2% -10.4% -5.6% -2.6% -8.6% -4.3% -4.32%
OCF 5Y 20.2% 24.8% 26.5% 26.6% 26.4% 20.4% 20.2% 18.2% 17.6% 15.1% 11.2% 10.5% 6.8% 4.2% 7.1% 3.0% 5.5% 5.4% 1.6% 2.6% 2.62%
Assets 3Y 28.6% 28.6% 35.2% 35.2% 35.2% 35.2% 15.9% 15.9% 15.9% 15.9% -3.6% -3.6% -3.6% -3.6% -2.7% -2.7% -2.7% -2.7% -1.2% -1.2% -1.18%
Assets 5Y 23.2% 23.2% 17.3% 17.3% 17.3% 17.3% 14.4% 14.4% 14.4% 14.4% 17.8% 17.8% 17.8% 17.8% 8.7% 8.7% 8.7% 8.7% -2.3% -2.3% -2.31%
Equity 3Y 36.9% 36.9% -7.5% -7.5% -7.5% -7.5% -40.0% -40.0% -40.0% -40.0%
Book Value 3Y 31.4% 29.8% -7.3% -7.4% -7.4% -7.4% -40.0% -40.0% -40.0% -40.0%
Dividend 3Y 5.3% 2.3% -0.0% -1.6% -3.0% -3.1% -3.2% -3.5% -0.3% 1.9% 1.8% 1.6% 1.6% 1.6% 1.6% 1.7% 1.8% 1.9% 2.0% 1.9% 1.91%
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.78 0.84 0.87 0.87 0.88 0.91 0.92 0.88 0.85 0.84 0.81 0.75 0.68 0.64 0.62 0.65 0.67 0.71 0.74 0.82 0.816
Earnings Stability 0.03 0.03 0.35 0.34 0.40 0.38 0.62 0.22 0.46 0.17 0.06 0.02 0.09 0.04 0.07 0.18 0.17 0.33 0.19 0.32 0.315
Margin Stability 0.93 0.94 0.93 0.92 0.93 0.94 0.94 0.93 0.95 0.95 0.93 0.92 0.92 0.93 0.92 0.92 0.93 0.96 0.94 0.93 0.932
Rev. Growth Consistency 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.00 1.00 0.50 0.50 0.50 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
FCF Positive Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Earnings Persistence 0.98 0.99 0.50 0.50 0.50 0.50 0.99 0.84 0.87 0.50 0.50 0.92 0.85 0.91 0.95 0.88 0.88 0.50 1.00 0.95 0.948
Earnings Smoothness 0.96 0.98 0.14 0.17 0.38 0.44 0.97 0.51 0.63 0.31 0.16 0.77 0.52 0.76 0.87 0.65 0.66 0.27 0.99 0.86 0.860
ROE Trend 0.13 -0.16 -0.16 -0.35 -0.25 -0.05 -0.15 -0.13 0.71 0.75 0.62 0.28
Gross Margin Trend -0.10 -0.05 -0.03 -0.02 0.01 0.01 0.02 0.02 0.01 -0.03 -0.07 -0.07 -0.07 -0.00 0.04 0.05 0.08 0.07 0.07 0.07 0.073
FCF Margin Trend -0.03 0.01 0.02 0.01 0.01 -0.01 0.04 0.04 0.07 0.06 0.00 0.00 -0.09 -0.13 -0.10 -0.14 -0.07 -0.02 -0.06 -0.00 -0.003
Sustainable Growth Rate -88.5% -61.7% 16.0% 21.2% 20.9% 25.0% 11.0% -15.9% -9.9% -23.9% -41.1% -33.7% -39.4% -41.8% -98.6% -1.0% -1.1% -1.3% -270.0% -297.2% -297.20%
Internal Growth Rate 1.6% 2.1% 2.0% 2.5% 1.3%
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 3.07 2.99 1.97 1.83 1.81 1.68 2.11 3.19 2.94 3.92 4.70 3.79 3.49 3.22 4.40 3.91 5.12 8.71 4.50 5.82 5.823
FCF/OCF 0.96 0.96 0.97 0.97 0.97 0.97 0.97 0.97 0.97 0.97 0.97 0.96 0.95 0.95 0.95 0.94 0.95 0.99 0.98 0.98 0.983
FCF/Net Income snapshot only 5.724
OCF/EBITDA snapshot only 1.254
CapEx/Revenue 1.6% 1.6% 1.4% 1.3% 1.2% 1.2% 1.2% 1.2% 1.3% 1.4% 1.4% 1.5% 1.6% 1.6% 1.7% 1.8% 1.8% 0.5% 0.5% 0.6% 0.57%
CapEx/Depreciation snapshot only 0.045
Accruals Ratio -0.12 -0.13 -0.08 -0.07 -0.07 -0.06 -0.09 -0.12 -0.12 -0.13 -0.13 -0.12 -0.10 -0.08 -0.11 -0.09 -0.11 -0.14 -0.11 -0.13 -0.131
Sloan Accruals snapshot only -0.068
Cash Flow Adequacy snapshot only 1.743
Earnings Quality Score snapshot only 0.750
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 5.2% 5.5% 4.5% 3.8% 4.0% 4.7% 3.9% 4.0% 4.7% 4.3% 4.1% 3.5% 3.7% 3.2% 3.6% 3.1% 3.5% 2.8% 2.9% 3.1% 3.12%
Dividend/Share $4.97 $5.09 $5.21 $5.32 $5.44 $5.55 $5.65 $5.73 $5.81 $5.88 $5.95 $6.01 $6.08 $6.15 $6.22 $6.31 $6.40 $6.49 $6.57 $6.66 $6.74
Payout Ratio 1.3% 1.2% 80.2% 75.8% 76.5% 73.5% 84.9% 1.3% 1.2% 1.6% 2.2% 1.8% 2.0% 2.1% 2.6% 2.7% 3.0% 4.8% 2.8% 3.2% 3.24%
FCF Payout Ratio 45.1% 41.7% 42.1% 42.9% 43.5% 44.9% 41.4% 43.3% 41.5% 42.1% 47.8% 48.7% 60.6% 69.8% 61.8% 72.7% 62.2% 55.9% 62.3% 56.6% 56.64%
Total Payout Ratio 1.5% 1.3% 88.3% 88.8% 89.2% 85.5% 97.4% 1.6% 1.4% 1.9% 2.6% 2.0% 2.3% 2.4% 3.0% 3.0% 3.4% 5.4% 3.0% 3.7% 3.65%
Div. Increase Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Chowder Number 0.37 0.31 0.24 0.18 0.13 0.14 0.12 0.12 0.11 0.10 0.09 0.08 0.08 0.08 0.08 0.08 0.09 0.08 0.09 0.09 0.088
Buyback Yield 0.7% 0.7% 0.4% 0.6% 0.7% 0.8% 0.6% 0.8% 0.9% 0.8% 0.8% 0.4% 0.5% 0.4% 0.6% 0.4% 0.4% 0.3% 0.2% 0.4% 0.39%
Net Buyback Yield 0.7% 0.7% 0.4% 0.6% 0.7% 0.8% 0.6% 0.8% 0.9% 0.8% 0.8% 0.4% 0.5% 0.4% 0.6% 0.4% 0.4% 0.1% 0.0% 0.1% 0.15%
Total Shareholder Return 5.9% 6.2% 4.9% 4.4% 4.7% 5.4% 4.5% 4.7% 5.6% 5.1% 4.9% 3.9% 4.2% 3.7% 4.2% 3.5% 3.9% 2.9% 2.9% 3.2% 3.24%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 1.11 1.04 0.89 0.89 0.90 0.91 0.88 0.84 0.83 0.81 0.78 0.80 0.76 0.71 1.15 1.16 1.24 1.44 0.64 0.61 0.610
Interest Burden (EBT/EBIT) 0.71 0.74 0.84 0.86 0.86 0.87 0.86 0.80 0.82 0.78 0.74 0.76 0.74 0.73 0.57 0.56 0.51 0.37 0.70 0.67 0.672
EBIT Margin 0.16 0.18 0.27 0.29 0.29 0.29 0.27 0.20 0.23 0.19 0.16 0.18 0.17 0.18 0.12 0.11 0.10 0.08 0.16 0.14 0.141
Asset Turnover 0.45 0.46 0.38 0.38 0.39 0.39 0.41 0.40 0.39 0.39 0.40 0.40 0.40 0.41 0.42 0.43 0.43 0.44 0.45 0.47 0.467
Equity Multiplier 48.87 48.87 10.43 10.43 10.43 10.43 8.74 8.74 8.74 8.74 9.90 9.90 9.90 9.90 19.72 19.72 19.72 19.72 4893.11 4893.11 4893.109
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $3.75 $4.24 $6.49 $7.02 $7.12 $7.55 $6.66 $4.27 $4.90 $3.68 $2.74 $3.38 $3.01 $2.89 $2.41 $2.37 $2.13 $1.35 $2.39 $2.05 $2.05
Book Value/Share $7.36 $7.36 $8.67 $8.67 $8.68 $8.68 $9.70 $9.72 $9.74 $9.74 $5.85 $5.84 $5.85 $5.85 $1.88 $1.88 $1.88 $1.88 $-1.84 $-1.84 $15.50
Tangible Book/Share $-57.95 $-57.92 $-52.26 $-52.26 $-52.32 $-52.32 $-46.31 $-46.36 $-46.49 $-46.49 $-43.76 $-43.74 $-43.78 $-43.76 $-51.72 $-51.75 $-51.75 $-51.75 $-51.61 $-51.61 $-51.61
Revenue/Share $30.25 $31.05 $31.61 $31.90 $32.29 $32.56 $32.65 $31.95 $31.63 $31.13 $30.65 $30.68 $31.06 $31.34 $31.77 $32.37 $32.92 $33.66 $34.48 $35.41 $35.41
FCF/Share $11.02 $12.20 $12.37 $12.40 $12.51 $12.34 $13.64 $13.24 $14.00 $13.96 $12.45 $12.35 $10.04 $8.82 $10.06 $8.68 $10.29 $11.61 $10.54 $11.76 $11.76
OCF/Share $11.52 $12.69 $12.81 $12.83 $12.91 $12.72 $14.03 $13.64 $14.42 $14.41 $12.89 $12.80 $10.52 $9.32 $10.61 $9.26 $10.88 $11.77 $10.73 $11.96 $11.96
Cash/Share $4.77 $4.77 $5.53 $5.53 $5.53 $5.53 $5.19 $5.20 $5.21 $5.21 $7.23 $7.23 $7.24 $7.23 $3.13 $3.13 $3.13 $3.13 $2.96 $2.96 $5.29
EBITDA/Share $9.74 $10.29 $13.46 $13.92 $13.83 $14.25 $13.60 $11.15 $12.10 $10.73 $9.69 $10.44 $10.21 $10.29 $8.41 $8.36 $7.99 $7.22 $9.94 $9.54 $9.54
Debt/Share $49.02 $48.99 $43.63 $43.63 $43.68 $43.68 $36.10 $36.14 $36.25 $36.25 $33.93 $33.91 $33.95 $33.93 $38.26 $38.28 $38.28 $38.28 $38.93 $38.93 $38.93
Net Debt/Share $44.25 $44.22 $38.10 $38.10 $38.14 $38.14 $30.91 $30.95 $31.03 $31.03 $26.70 $26.68 $26.71 $26.70 $35.13 $35.15 $35.15 $35.15 $35.97 $35.97 $35.97
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score 2.072
Altman Z-Prime snapshot only 2.301
Piotroski F-Score 6 6 7 6 7 6 8 6 6 5 4 4 5 5 6 7 6 6 6 6 6
Beneish M-Score -1.85 -1.96 -2.77 -2.75 -2.86 -2.66 -2.85 -2.92 -2.87 -2.91 -3.03 -3.11 -2.99 -3.08 -3.02 -2.90 -3.07 -3.03 -2.94 -2.99 -2.990
Ohlson O-Score snapshot only -7.339
Net-Net WC snapshot only $-60.95
EVA snapshot only $5102898995.82
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only BB+
Credit Score 31.31 32.91 35.75 43.98 44.49 39.04 55.69 53.05 53.83 48.80 41.80 47.65 42.14 42.12 27.79 33.12 33.36 37.92 38.33 45.78 45.781
Credit Grade snapshot only 11
Credit Trend snapshot only 12.662
Implied Spread (bps) snapshot only 400.000
Industry Credit Rank snapshot only 24
Sector Credit Rank snapshot only 43

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms